FDA Approved: VERSACLOZ — Supplemental Application (TruPharma LLC)

View source ↗

Summary

The FDA approved a supplemental application for VERSACLOZ (clozapine) filed by TruPharma LLC. Clozapine is an antipsychotic indicated for schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• VERSACLOZ (CLOZAPINE)

Snippet

SUPPL AP for VERSACLOZ (CLOZAPINE)